Posted by Michael Wonder on 11 Oct 2017
An FDA program to approve old drugs causes higher prices and shortages
11 October 2017 - In 2006, the FDA launched a program to require drug makers to win approval of medicines that — believe it or not — were being sold without the agency’s imprimatur or remove them from the market.
At the time, hundreds of treatments were readily available because some companies failed to comply with a 1962 law mandating companies prove drugs were effective.
Unfortunately, the FDA effort has had some unforeseen consequences.
